National Asset Management, Inc. Edwards Lifesciences Corp Transaction History

National Asset Management, Inc.

$3.51 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$72.54 - $95.56 $681,150 - $897,308	9,390 Added 80.43%	21,065 $2.01 Million
Q4 2023 Mar 15, 2024	SELL	$61.71 - $77.76 $579,456 - $730,166	-9,390 Reduced 44.58%	11,675 $890,000
Q3 2023 Dec 01, 2023	SELL	$69.28 - $93.38 $76,069 - $102,531	-1,098 Reduced 4.95%	21,065 $1.46 Million
Q2 2023 Jul 27, 2023	BUY	$81.41 - $94.33 $74,083 - $85,840	910 Added 4.28%	22,163 $2.09 Million
Q1 2023 May 17, 2023	SELL	$74.26 - $84.51 $989,143 - $1.13 Million	-13,320 Reduced 38.53%	21,253 $1.76 Million
Q4 2022 Feb 21, 2023	SELL	$68.3 - $87.44 $331,528 - $424,433	-4,854 Reduced 12.31%	34,573 $2.58 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $153,537 - $199,988	1,864 Added 4.96%	39,427 $3.26 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $89,268 - $132,374	1,032 Added 2.82%	37,563 $3.57 Million
Q1 2022 May 02, 2022	BUY	$101.96 - $128.34 $7,137 - $8,983	70 Added 0.19%	36,531 $4.3 Million
Q4 2021 Jan 28, 2022	SELL	$106.37 - $130.68 $163,065 - $200,332	-1,533 Reduced 4.03%	36,461 $4.72 Million
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $359,876 - $429,256	-3,497 Reduced 8.43%	37,994 $4.3 Million
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $895,159 - $1.12 Million	10,677 Added 34.65%	41,491 $4.3 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $1.6 Million - $1.84 Million	20,336 Added 194.08%	30,814 $2.58 Million
Q4 2020 Feb 04, 2021	SELL	$71.69 - $91.23 $119,077 - $151,533	-1,661 Reduced 13.68%	10,478 $956,000
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $107,772 - $140,253	1,604 Added 15.23%	12,139 $969,000
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $447,776 - $598,824	7,782 Added 282.67%	10,535 $729,000
Q1 2020 May 06, 2020	BUY	$52.41 - $81.0 $31,131 - $48,114	594 Added 27.51%	2,753 $520,000
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $75,069 - $85,948	1,047 Added 94.15%	2,159 $505,000
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $2,277 - $2,790	-37 Reduced 3.22%	1,112 $245,000
Q2 2019 Aug 05, 2019	BUY	$55.74 - $64.41 $64,045 - $74,007	1,149 New	1,149 $213,000

Others Institutions Holding EW

# of Institutions

1,352

Shares Held

469M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.45 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.63 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.24 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.87 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$962 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account